awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51680781-08FDB0D2-C4F5-4C81-A30D-E3255587B54A
Q51680781-08FDB0D2-C4F5-4C81-A30D-E3255587B54A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51680781-08FDB0D2-C4F5-4C81-A30D-E3255587B54A
Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization.
P2860
Q51680781-08FDB0D2-C4F5-4C81-A30D-E3255587B54A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51680781-08FDB0D2-C4F5-4C81-A30D-E3255587B54A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc52305301a35c00afe457cb74e6473d62fd18d7
P2860
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.